Global Head Clinical Phamacology
Janssen Research & Development LLC
Dr. Ouellet leads a global team of clinical pharmacologists, pharmacometricians and the Phase 1 Clinical Pharmacology Unit at Janssen (Johnson & Johnson). She has more than 25 years of experience in the pharmaceutical industry and is a career-long champion of quantitative clinical pharmacology approaches. She ensures that Clinical Pharmacology & Pharmacometrics provides end-to-end clinical pharmacology and pharmacometric/pharmacodynamic modeling expertise, starting at First-in-Human study to registration through clinical drug development projects for small and large molecules across all Janssen Therapeutic Areas. Dr. Ouellet has a BPharm degree from the Univ of Montreal and graduated with MS and PhD degrees from the Univ of North Carolina at Chapel Hill.
During her career, Dr. Ouellet has been active in the scientific community and currently serves on the Board of Directors of the American Society of Clinical Pharmacology and Therapeutics. She is a fellow of the Int’l Society of Pharmacometrics (ISoP), was awarded the ISoP Leadership Award in November 2020 and served on their board of directors from 2014 to 2017. She has published more than 70 original articles, multiple abstracts and served as a peer reviewer for different journals. She has chaired annual scientific meetings, various symposiums and presented at multiple conferences.
2 - ACCP Honorary Fellowship Award: The 5 Top Things I Learned
Sunday, September 10, 2023
11:45 AM - 1:15 PM PT
Disclosure information not submitted.